Whither Recombinant Human Leptin Treatment for HIV-Associated Lipoatrophy and the Metabolic Syndrome?

Documenti analoghi

• Leptin and Adiponectin in the HIV Associated Metabolic Syndrome: Physiologic and Therapeutic Implications
  di: Tsiodras, Sotirios, et al.
  Pubblicazione: (2006)
• Leptin in Relation to the Lipodystrophy-Associated Metabolic Syndrome
  di: Christos S. Mantzoros
  Pubblicazione: (2012-06-01)
• Leptin in Relation to the Lipodystrophy-Associated Metabolic Syndrome
  di: Mantzoros, Christos S.
  Pubblicazione: (2012)
• The Effects of Recombinant Human Leptin on Visceral Fat, Dyslipidemia, and Insulin Resistance in Patients with Human Immunodeficiency Virus-Associated Lipoatrophy and Hypoleptinemia
  di: Mulligan, Kathleen, et al.
  Pubblicazione: (2009)
• r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans
  di: Brennan, Aoife M., et al.
  Pubblicazione: (2008)